A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Germline BRCA mutations have an adverse impact on both progression-free and overall survival in patients with hormone receptor-positive/HER2-negative metastatic ...

Add Yahoo as a preferred source to see more of our stories on Google. In an essay shared to Today.com, the TV presenter explained that she learned of her diagnosis on 26 June. Her doctor had recently ...

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of JUF, and is supported in part by the Michael Reese Health Trust.

Gila Pfeffer is a humor writer who splits her time between NYC and London. The following is an adapted excerpt from her memoir, "Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences." ...

Man patient speaking talking doctor receiving chemotherapy treatment iv infusion Platinum chemotherapy is a valid treatment option in patients with BRCA mutations, according to investigators. Poly ADP ...

These results suggest that tumors associated with BRCA1 mutations may be divided into two distinct groups, triple-negative and non–triple-negative groups. Future studies should seek to determine ...

Akeega, the first dual action tablet with a PARP inhibitor and abiraterone acetate, was approved for the treatment of patients with suspected or confirmed BRCA-positive metastatic castration-resistant ...

The FDA companion diagnostic designation for FoundationOne CDx may improve access to niraparib/abiraterone acetate for eligible patients with metastatic castration-resistant prostate cancer (mCRPC) ...

Today show star Jill Martin has been diagnosed with breast cancer. In an essay shared to Today, the TV presenter explained that she learned of her diagnosis on 26 June. Her doctor had recently ...